Common use of Development of Product by Company Clause in Contracts

Development of Product by Company. Starting on the Continuation Date, except as set forth in Section 2.6 and Section 4.1 above, Company shall have the exclusive right, and sole responsibility and decision-making authority, to research, Develop the Collaboration Compound and Product in the Territory and to conduct (either itself or through its Affiliates, agents, subcontractors and/or Sublicensees) all Clinical Trials and non-clinical studies necessary to obtain Regulatory Approval for Product in the Field in the Territory in accordance with the Development Plan, and to Manufacture Collaboration Compound and Product for Development and Commercialization in the Territory. Licensor shall retain all other rights not described in Section 4.1 above to research, Develop and Commercialize Product outside the Territory, at its own cost and expense, and to Manufacture Collaboration Compound and Product for Development and Commercialization in the Territory. Notwithstanding the foregoing, each Party shall disclose to the other Party all non-clinical and clinical data relating to Collaboration Compound and Product generated by either Party in the Territory and Licensor outside the Territory. Each Party hereby grants the other Party the right to use such data for Development and Commercialization of the Collaboration Compound and Product and to obtain Regulatory Approval by Company in the Territory and Licensor outside the Territory, and to Manufacture Collaboration Compound and Product for Development and Commercialization by Company in the Territory and by Licensor outside the Territory.

Development of Product by Company. Starting on the Continuation Date, except as set forth in Section 2.6 2.9 and Section 4.1 above, Company shall have the exclusive right, and sole responsibility and decision-making authority, to research, research and Develop the Collaboration Compound and Product in the Company Territory and to conduct (either itself or through its Affiliates, agents, subcontractors and/or Sublicensees) all Clinical Trials and non-clinical studies necessary to obtain Regulatory Approval for Product in the Field in the Company Territory in accordance with the Development Plan, and to Manufacture Collaboration Compound and Product for Development and Commercialization in the Company Territory. Licensor shall retain all other rights not described in Section 4.1 above to research, Develop and Commercialize Product outside in the Reserved Territory, at its own cost and expense, and to Manufacture Collaboration Compound and Product for Development and Commercialization in the Territory. Notwithstanding the foregoing, each Party shall disclose to the other Party all non-clinical and clinical data relating to Collaboration Compound and Product generated by either Party in the Company Territory and Licensor outside in the Reserved Territory. Each Party hereby grants the other Party the right to use such data for Development and Commercialization of the Collaboration Compound and Product and to obtain Regulatory Approval by Company in the Company Territory and Licensor outside in the Reserved Territory, and to Manufacture Collaboration Compound and Product for Development and Commercialization by Company in the Company Territory and by Licensor outside in the Reserved Territory.